c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Bristol to evaluate navlimetostat in combination with Erasca asset
Seeking Alpha | Nov 18, 2026 1:19 PM EST
Read original article